2019

1. Clinical utility of plasma-based digital next-generation sequencing in oncogene-driven non-small-cell lung cancer patients with tyrosine kinase inhibitor resistance

   Lung Cancer, Vol. 134, pp. 72-78

2. Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping

   Annals of Oncology, Vol. 30, Núm. 2, pp. 290-296